In this study, we found that Menin is a new ubiquitin-proteasome-regulated HSP27 partner and highlights a new CRPC driving mechanism that can serve as a therapeutic target to restore PC treatment sensitivity. Here, MEN1 is linked to pachyonychia congenita.